Veralox Therapeutics
Website unreachable. The provided URL returned HTTP 403 Forbidden (nginx), so no company content was available to extract.
Industries
Biotechnology
Medical
Pharmaceutical
Therapeutics
Nr. of Employees
small (1-50)
Products
VLX-1005
An intravenous investigational therapeutic candidate being evaluated in Phase 2 trials for heparin-induced thrombocytopenia and preclinical development.
VLX-2000 Series
An oral investigational small-molecule series in preclinical development and discovery for Type 1 Diabetes and undisclosed indications.
VLX-1005
An intravenous investigational therapeutic candidate being evaluated in Phase 2 trials for heparin-induced thrombocytopenia and preclinical development.
VLX-2000 Series
An oral investigational small-molecule series in preclinical development and discovery for Type 1 Diabetes and undisclosed indications.